Opiant Pharmaceuticals Inc. (OPNT) Fundamentals

Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.
SHARE INFORMATION
Market Cap$ 103,976,418
Shares Outstanding5,167,814
Float4,914,871
Percent Float95.11%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 40,725,185
Latest Fiscal EPS$ 0.31
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions78
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months91,992
Institutional Holdings Percent50.8%
Institutional Sold Previous 3 Months40,036
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent10.3
Insider Sold Previous 3 Months-
Insider Shares Owned531,069
TRADING INFO
52 Week High$ 37.71
52 Week Low$ 7.34
52 Week High Change$ -16.65
21 Day Moving Average$ 15.1102
21 Day Extended Moving Average$ 16.4816
50 Day Moving Average$ 12.2829
50 Day Extended Moving Average$ 13.801
200 Day Moving Average$ 15.4157
200 Day Extended Moving Average$ 14.8548
10 Day Average Volume156,637
20 Day Average Volume179,309
30 Day Average Volume123,689
50 Day Average Volume80,954
Alpha-0.013495
Beta0.5074
Standard Deviation0.172721
R20.024197
7 Day Price Change$ 0.03
7 Day Percent Change0.15%
21 Day Price Change$ 10.62
21 Day Percent Change111.79%
30 Day Price Change$ 10.41
30 Day Percent Change107.17%
Month to Date Price Change$ 10.59
Month to Date Percent Change111.12%
Quarter to Date Price Change$ 9.37
Quarter to Date Percent Change87.16%
180 Day Price Change$ 5.46
180 Day Percent Change37.24%
200 Day Price Change$ 7.65
200 Day Percent Change61.35%
Year to Date Price Change$ -13.51
Year to Date Percent Change-40.17%

Opiant Pharmaceuticals Inc. (OPNT) Key Ratios

PROFITABILITY
EBIT Margin-178.3%
EBITDA Margin-174.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count-62.52%
Gross Margin78.0%
Profit Margin TOT-62.52%
INCOME STATEMENTS
Revenue$ 17,555,977
Revenue Per Share$ 3.3972
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.10
Total Debt To Equity0.80
Int Coverage-18.20
Current Ratio5.50
Leverage Ratio1.60
Quick Ratio5.00
Long Term Debt To Capital0.41
VALUATION MEASURES
PE Ratio-3.10
Enterprise Value$ 85,010,850
Price to Sales5.9226
Price to Free Cash-6.50
PE High Last 5 Years61.10
Price To Book5.10
Price To Cash Flow38.30
PE Low Last 5 Years-17.30
Price to Tangible Book5.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.90
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-59.66
Return on Equity-105.87
Return on Capital-65.09

Opiant Pharmaceuticals Inc. (OPNT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMaloneBailey, LLP
CEORoger Crystal
Emplyoees37
Last AuditUQ
CIK0001385508
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address233 Wilshire Boulevard
Suite 280
Santa Monica, CA 90401
Websitehttps://www.opiant.com
Facsimile+1 917 322-2105
Telephone+1 310 598-5410
EmailInvestor.relations@opiant.com


Your Recent History
NASDAQ
OPNT
Opiant Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.